New, Robust and Inexpensive Technique for Protein Analysis in Tissues

A new technique to study proteins, which does not require advanced equipment, specialized labs or expensive reagents, has been developed at Uppsala University, Sweden. The technique could be further developed to be used in point of care devices, for instance for diagnostic purposes. The possibility to identify and localize proteins in tissues is essential for understanding disease mechanisms and for diagnostics. However, today very advanced instruments are often needed to study proteins and how they interact with each other. An example is the microscopy technique that was awarded last year's Nobel Prize in chemistry; super resolution fluorescence microscopy.

Such equipment is expensive to purchase and often requires special training to handle. In order to use protein detection for diagnostic purposes, e.g. in a clinic, new, less complicated methods to study proteins are needed. Such methods should be temperature insensitive and not require expensive instruments, costly reagents or specially trained staff.

In the most recent issue of the journal Nature Communications the researchers present a technique that could be used by for instance hospital staff, to detect relevant proteins. The technique is based on the binding of antibodies, either to two sites on the same protein or to two proteins that are localized very close to each other. The antibodies have been linked to DNA strands that will attach to each other if they are close enough. When this happens a chain reaction will start in which increasing numbers of DNA strands are attached. To each DNA strand a fluorescent substance has been linked, which will emit light when it is irradiated with light of a certain wavelength.

"When the chain reaction has run for a while enough fluorescent molecules have been incorporated to allow us to observe them as very bright dots in a microscope, reflecting the presence of a protein of interest. The more dots there more protein," says Ola Söderberg, who has developed the technique together with Masood Kamali-Mogaddam and their research teams.

The chain reaction does not include any enzymes, which means that it can take place at room temperature. The microscopes needed to study the bright dots are relatively simple and commonly available in hospital and research labs. Since two antibodies are bound in the first step "false" signals can be avoided, making the reaction very specific for the studied protein.

"All this implies that our technique can be used as a robust and inexpensive method to localize proteins in tissues. We hope that it soon can be used both for clinical applications and for research purposes," says Ola Söderberg.

The technique has been developed in collaboration with researchers in Uppsala, Scotland and Austria. The results have been published online in the journal Nature Communications.

Reference: Proximity Dependent Initiation of Hybridization Chain Reaction, Nature Communications, DOI: 10.1038/ncomms8294

Science for Life Laboratory (SciLifeLab) is a national centre for molecular biosciences with the focus on health and environmental research. The centre combines advanced technical know-how and state-of-the art equipment with a broad knowledge of translational medicine and molecular bioscience.

Uppsala University - quality, knowledge, and creativity since 1477 World-class research and outstanding education of global benefit to society, business, and culture. Uppsala University is one of northern Europe's highest ranked academic institutions.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...